Search alternatives:
significantly better » significantly greater (Expand Search), significantly higher (Expand Search), significantly lower (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
better decrease » greater decrease (Expand Search), teer decrease (Expand Search), between decreased (Expand Search)
significantly better » significantly greater (Expand Search), significantly higher (Expand Search), significantly lower (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
better decrease » greater decrease (Expand Search), teer decrease (Expand Search), between decreased (Expand Search)
-
2181
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2182
-
2183
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2184
-
2185
-
2186
-
2187
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2188
-
2189
-
2190
-
2191
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2192
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2193
-
2194
-
2195
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2196
-
2197
-
2198
-
2199
-
2200